Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm

References

• Kwiatkowski TJ Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323:1205 - 8; http://dx.doi.org/10.1126/science.1166066; PMID: 19251627
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323:1208 - 11; http://dx.doi.org/10.1126/science.1165942; PMID: 19251628
   PubMed Web of Science ®Google Scholar
• Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, Mishra M, Ajroud-Driss S, Heller S, Sufit R, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 2010; 67:739 - 48; PMID: 20517935
   PubMed Web of Science ®Google Scholar
• Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132:2922 - 31; http://dx.doi.org/10.1093/brain/awp214; PMID: 19674978
   PubMed Web of Science ®Google Scholar
• Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009; 118:605 - 16; http://dx.doi.org/10.1007/s00401-009-0581-5; PMID: 19669651
   PubMed Web of Science ®Google Scholar
• Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, Kuroda S, Mackenzie IR. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009; 118:617 - 27; http://dx.doi.org/10.1007/s00401-009-0598-9; PMID: 19830439
   PubMed Web of Science ®Google Scholar
• Cohen NR, Hammans SR, Macpherson J, Nicoll JA. New neuropathological findings in Unverricht-Lundborg disease: neuronal intranuclear and cytoplasmic inclusions. Acta Neuropathol 2011; 121:421 - 7; http://dx.doi.org/10.1007/s00401-010-0738-2; PMID: 20721566
   PubMed Web of Science ®Google Scholar
• Da Cruz S, Cleveland DW. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 2011; 21:904 - 19; http://dx.doi.org/10.1016/j.conb.2011.05.029; PMID: 21813273
   PubMed Web of Science ®Google Scholar
• Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat 2013; 34:812 - 26; http://dx.doi.org/10.1002/humu.22319; PMID: 23559573
   PubMed Web of Science ®Google Scholar
• Dormann D, Madl T, Valori CF, Bentmann E, Tahirovic S, Abou-Ajram C, Kremmer E, Ansorge O, Mackenzie IR, Neumann M, et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J 2012; 31:4258 - 75; http://dx.doi.org/10.1038/emboj.2012.261; PMID: 22968170
   PubMed Web of Science ®Google Scholar
• Kedersha N, Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol 2007; 431:61 - 81; http://dx.doi.org/10.1016/S0076-6879(07)31005-7; PMID: 17923231
   PubMed Web of Science ®Google Scholar
• Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ Jr., Sapp P, McKenna-Yasek D, Brown RH Jr., Hayward LJ. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 2010; 19:4160 - 75; http://dx.doi.org/10.1093/hmg/ddq335; PMID: 20699327
   PubMed Web of Science ®Google Scholar
• Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 2010; 29:2841 - 57; http://dx.doi.org/10.1038/emboj.2010.143; PMID: 20606625
   PubMed Web of Science ®Google Scholar
• Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, Jia J, Zhu H. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 2011; 32:2323.e27 - 40; http://dx.doi.org/10.1016/j.neurobiolaging.2010.06.010; PMID: 20674093
   PubMedGoogle Scholar
• Ito D, Seki M, Tsunoda Y, Uchiyama H, Suzuki N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 2011; 69:152 - 62; http://dx.doi.org/10.1002/ana.22246; PMID: 21280085
   PubMed Web of Science ®Google Scholar
• Bentmann E, Neumann M, Tahirovic S, Rodde R, Dormann D, Haass C. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem 2012; 287:23079 - 94; http://dx.doi.org/10.1074/jbc.M111.328757; PMID: 22563080
   PubMed Web of Science ®Google Scholar
• Cléry A, Blatter M, Allain FH. RNA recognition motifs: boring? Not quite. Curr Opin Struct Biol 2008; 18:290 - 8; http://dx.doi.org/10.1016/j.sbi.2008.04.002; PMID: 18515081
   PubMed Web of Science ®Google Scholar
• Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 2009; 37:1799 - 808; http://dx.doi.org/10.1093/nar/gkp013; PMID: 19174564
   PubMed Web of Science ®Google Scholar
• Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J, Moreau-Gachelin F. Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 2001; 276:6807 - 16; http://dx.doi.org/10.1074/jbc.M008304200; PMID: 11098054
   PubMed Web of Science ®Google Scholar
• Liu X, Niu C, Ren J, Zhang J, Xie X, Zhu H, Feng W, Gong W. The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site. Biochim Biophys Acta 2013; 1832:375 - 85; http://dx.doi.org/10.1016/j.bbadis.2012.11.012; PMID: 23200923
   PubMed Web of Science ®Google Scholar
• Li YR, King OD, Shorter J, Gitler AD. Stress granules as crucibles of ALS pathogenesis. J Cell Biol 2013; 201:361 - 72; http://dx.doi.org/10.1083/jcb.201302044; PMID: 23629963
   PubMed Web of Science ®Google Scholar
• Wolozin B. Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener 2012; 7:56; http://dx.doi.org/10.1186/1750-1326-7-56; PMID: 23164372
   PubMed Web of Science ®Google Scholar
• Kedersha N, Cho MR, Li W, Yacono PW, Chen S, Gilks N, Golan DE, Anderson P. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol 2000; 151:1257 - 68; http://dx.doi.org/10.1083/jcb.151.6.1257; PMID: 11121440
   PubMed Web of Science ®Google Scholar
• Zhang J, Okabe K, Tani T, Funatsu T. Dynamic association-dissociation and harboring of endogenous mRNAs in stress granules. J Cell Sci 2011; 124:4087 - 95; http://dx.doi.org/10.1242/jcs.090951; PMID: 22135363
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130 - 3; http://dx.doi.org/10.1126/science.1134108; PMID: 17023659
   PubMed Web of Science ®Google Scholar
• Baloh RH. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?. Curr Opin Neurol 2012; 25:701 - 7; http://dx.doi.org/10.1097/WCO.0b013e32835a269b; PMID: 23041957
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D, Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 2007; 27:10530 - 4; http://dx.doi.org/10.1523/JNEUROSCI.3421-07.2007; PMID: 17898224
   PubMed Web of Science ®Google Scholar
• Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008; 4:e1000193; http://dx.doi.org/10.1371/journal.pgen.1000193; PMID: 18802454
   PubMed Web of Science ®Google Scholar
• Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M, et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 2008; 173:182 - 94; http://dx.doi.org/10.2353/ajpath.2008.080003; PMID: 18535185
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Kaneko K, Nukina N. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site. Biochim Biophys Acta 2011; 1812:1577 - 83; http://dx.doi.org/10.1016/j.bbadis.2011.09.005; PMID: 21946215
   PubMed Web of Science ®Google Scholar
• Pesiridis GS, Tripathy K, Tanik S, Trojanowski JQ, Lee VMA. A “two-hit” hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem 2011; 286:18845 - 55; http://dx.doi.org/10.1074/jbc.M111.231118; PMID: 21454607
   PubMed Web of Science ®Google Scholar
• Huang YC, Lin KF, He RY, Tu PH, Koubek J, Hsu YC, Huang JJ. Inhibition of TDP-43 aggregation by nucleic acid binding. PLoS One 2013; 8:e64002; http://dx.doi.org/10.1371/journal.pone.0064002; PMID: 23737961
   PubMed Web of Science ®Google Scholar
• Kino Y, Washizu C, Aquilanti E, Okuno M, Kurosawa M, Yamada M, Doi H, Nukina N. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res 2011; 39:2781 - 98; http://dx.doi.org/10.1093/nar/gkq1162; PMID: 21109527
   PubMed Web of Science ®Google Scholar
• Shelkovnikova TA, Ustyugov AA, Smirnov AP, Skvortsova VI, Buchman VL, Bachurin SO, Ninkina NN. FUS gene mutations associated with familiar forms of amyotrophic lateral sclerosis affect cellular localization and aggregation properties of the encoded protein. Dokl Biochem Biophys 2011; 438:123 - 6; http://dx.doi.org/10.1134/S1607672911030045; PMID: 21725888
   PubMed Web of Science ®Google Scholar
• Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000; 10:524 - 30; http://dx.doi.org/10.1016/S0962-8924(00)01852-3; PMID: 11121744
   PubMed Web of Science ®Google Scholar
• Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 2001; 276:36337 - 43; http://dx.doi.org/10.1074/jbc.M104236200; PMID: 11470789
   PubMed Web of Science ®Google Scholar
• Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123:1191 - 201; http://dx.doi.org/10.1242/jcs.051672; PMID: 20356930
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 2012; 21:3776 - 84; http://dx.doi.org/10.1093/hmg/dds199; PMID: 22645277
   PubMed Web of Science ®Google Scholar
• Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Bruneteau G, Pradat PF, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet 2010; 47:554 - 60; http://dx.doi.org/10.1136/jmg.2010.077180; PMID: 20577002
   PubMed Web of Science ®Google Scholar
• Groen EJ, van Es MA, van Vught PW, Spliet WG, van Engelen-Lee J, de Visser M, Wokke JH, Schelhaas HJ, Ophoff RA, Fumoto K, et al. FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol 2010; 67:224 - 30; http://dx.doi.org/10.1001/archneurol.2009.329; PMID: 20142531
   PubMed Web of Science ®Google Scholar
• Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, Blumbergs PC, Vucic S, Kiernan MC, Nicholson GA. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry 2010; 81:639 - 45; http://dx.doi.org/10.1136/jnnp.2009.194399; PMID: 19965854
   PubMed Web of Science ®Google Scholar
• Caccamo A, Majumder S, Oddo S. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43. Am J Pathol 2012; 180:293 - 302; http://dx.doi.org/10.1016/j.ajpath.2011.09.022; PMID: 22067910
   PubMed Web of Science ®Google Scholar
• Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2010; 107:3858 - 63; http://dx.doi.org/10.1073/pnas.0912417107; PMID: 20133711
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2009; 106:7607 - 12; http://dx.doi.org/10.1073/pnas.0900688106; PMID: 19383787
   PubMed Web of Science ®Google Scholar
• Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, Neumann M, Kremmer E, Matsuwaki T, Yamanouchi K, Nishihara M, et al. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J Neurochem 2009; 110:1082 - 94; http://dx.doi.org/10.1111/j.1471-4159.2009.06211.x; PMID: 19522733
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, Liu J, Ye H, Shen Y, Li Y, et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell 2011; 2:477 - 86; http://dx.doi.org/10.1007/s13238-011-1065-7; PMID: 21748598
   PubMed Web of Science ®Google Scholar
• Miguel L, Avequin T, Delarue M, Feuillette S, Frébourg T, Campion D, Lecourtois M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol Aging 2012; 33:1008.e1 - 15; http://dx.doi.org/10.1016/j.neurobiolaging.2011.10.008; PMID: 22118902
   PubMedGoogle Scholar
• Murakami T, Yang SP, Xie L, Kawano T, Fu D, Mukai A, Bohm C, Chen F, Robertson J, Suzuki H, et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum Mol Genet 2012; 21:1 - 9; http://dx.doi.org/10.1093/hmg/ddr417; PMID: 21949354
   PubMed Web of Science ®Google Scholar
• Huang C, Zhou H, Tong J, Chen H, Liu YJ, Wang D, Wei X, Xia XG. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet 2011; 7:e1002011; http://dx.doi.org/10.1371/journal.pgen.1002011; PMID: 21408206
   PubMed Web of Science ®Google Scholar
• Shelkovnikova TA, Peters OM, Deykin AV, Connor-Robson N, Robinson H, Ustyugov AA, Bachurin SO, Ermolkevich TG, Goldman IL, Sadchikova ER, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J Biol Chem 2013; 288:25266 - 74; http://dx.doi.org/10.1074/jbc.M113.492017; PMID: 23867462
   PubMed Web of Science ®Google Scholar